12-5-1　ⓔ文献

  1. Paris R, Charlotte F, et al: A systemic review of follow–up biopsies reveals disease progression in patients with non-alcoholic fatty liver. J Hepatol, 2013; 59: 550–556.

  2. Eslam M, Sanyal AJ, et al: MAFLD: a consensus–driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology, 2020; 158: 1999–2014.

  3. Eguchi Y, Hyogo H, et al: Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol, 2012; 47: 586–595.

  4. Cusi K: Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroetnterology, 2012; 142: 711–725.

  5. Sterling RK, Lissen E, et al: Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology, 2006; 43: 1317–1325.

  6. Sumida Y, Yoneda M, et al: Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population. BMC Gastroenterol, 2012; 12: 2.

  7. Castera L, Friedrich–Rust M, et al: Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology, 2019; 156: 1264–1281.e4.

  8. Matteoni CA, Younossi ZM, et al: Nonalcholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology, 1999; 116: 1413–1419.

  9. Kleiner DE, Brunt EM, et al: Design and validation of a histological scoreing system for nonalcoholic fatty liver disease. Hepatology, 2005; 41: 1313–1321.

  10. Bedossa P: FLIP Pathology Consortium. Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score I the evaluation of biopsies of nonalcoholic fatty liver disease. Hepatology, 2014; 60: 565–575.

  11. Vilar–Gomez E, Martinez–Perez Y, et al: Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology, 2015; 149: 367–378.

  12. Angulo P, Kleiner DE, et al: Liver fibrosis, but no other histologic features, is associated with long–term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology, 2015; 149: 389–397.